BioMimetic Therapeutics (BMTI) Posts Q1 Loss of 22c
Tweet
Share
E-mailGet Alerts BMTI Hot Sheet
Price: $9.49 --0%
Financial Fact:
Loss before income taxes: -4.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Loss before income taxes: -4.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) reported Q1 EPS of ($0.22), versus ($0.28) reported last year. Revenue for the quarter came in at $466.38 million, versus $398.7 million reported last year.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
